The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by European Medicines Agency (EMA) and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law. In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other national societies active in human pharmacology are invited to apply to become members. Institutions, pharma or service provider companies can apply for associate membership.
20.09.2024 – EUFEMED Workshop: “Making the Investigator Br ...
Location: University of Warsaw Faculty of Applied Linguistics Dobra 55 00-312 Warsaw, Poland Date: Friday, September 20, 2024 | 9:00 – 16:30 The primary objective of the Investigator Brochure (IB)… Read More ...14.06.2024 – EUFEMED Webinar: Preferences of Phase I partici ...
We live in rapidly changing times. Do we still know the expectations and preferences of our healthy trial participants? Do we know about their reasons for joining a trial and… Read More ...19.06.2024 – AFPT – Club Phase 1 webinar: First-In-Hum ...
Format: Webinar Date: Wednesday, June 19, 2024 from 3:00 PM to 4:00 PM CEST To start the clinical development, the first-in-human dose selection including the starting dose and the… Read More ...12-14.06.2024 – INTRODUCTORY COURSE IN EXPLORATORY MEDICINES ...
Format: In Person Training Date: From 12 April 2024 to 14 April 2024 Venue: Tagungshaus- und Bildungshaus des Bistums Limburg Wilhelm-Kempf-Haus 1 65207 Wiesbaden (Germany) AGAH is glad to… Read More ...26.04.2024 – ToxAIcology – AI as the New Frontier in R ...
Format: Webinar Date: Friday, April 26, 2024 from 4:00 PM to 5:30 PM Speaker: Thomas Hartung, Professor at Johns Hopkins Bloomberg School of Public Health The synergy of data generation and… Read More ...18-22 MAR 2024: “PRE-CLINICAL AND CLINICAL SAFETY IN EARLY DEVEL ...
EVENT DETAILS This will be the third time of presenting this course focused on pre-clinical and clinical safety in early development human trials. Delivered at the prestigious Henri Moissan Université… Read More ...DOWNLOAD PRESENTATIONS: 4th EUFEMED Conference – Mastering t ...
4th EUFEMED Conference – Mastering the New Time Pressure on Human Pharmacology Presentationsare now available, click the link below to reach the Presentations’ Page. Click Here to see List… Read More ...15.12.2023: EUFEMED Scientific Christmas lecture: The (early) clin ...
Scientific Christmas Lecture Webinar on 15 December 2023 at 16:00-17:30 CET Organiser: Jan De Hoon SAVE THE DATE! ...10 | 13-15 | 20 November 2023 – Module 3, EUFEMED Diploma Co ...
Module 3, EUFEMED Diploma Course in Human Pharmacology 10 November 2023 -online 13-15 November 2023, Bad Soden (Germany) 20 November 2023 -online REGISTER HERE ...15.09.2023: Patient/Participant engagement in exploratory clinical ...
Patient/Participant engagement in exploratory clinical development Webinar on 15 September 2023 at 16:00-17:30 CET Organiser: Ingrid Klingmann Register Here ...25-26.05.2023 – 4th EUFEMED Conference: Mastering the New Ti ...
EUFEMED is delighted to announce our 4th Conference on 25th – 26th May 2023 Pre-workshop on May 24, 2023 Langenbeck-Virchow Haus Berlin Germany The Conference is entitled Mastering the New… Read More ...13–17.03.2023: “Pre-Clinical and Clinical Safety in Early ...
The board of the Association Française de Pharmacologie Translationnelle – Le Club Phase 1 (AFPT-CP1) is pleased to announce that the course “Pre-Clinical and Clinical Safety in Early Development Human… Read More ...
Upcoming events
20.09.2024 – EUFEMED Workshop: “Making the Investigator Brochure truly fit for purpose in early medicines development”
Location: University of Warsaw Faculty of Applied Linguistics Dobra 55 00-312 Warsaw, Poland Date: Friday, September 20, 2024 | 9:00 – 16:30 The primary objective of the Investigator Brochure (IB)… Read More
DOWNLOAD PRESENTATIONS: 4th EUFEMED Conference – Mastering the New Time Pressure on Human Pharmacology
4th EUFEMED Conference – Mastering the New Time Pressure on Human Pharmacology Presentationsare now available, click the link below to reach the Presentations’ Page. Click Here to see List… Read More
About us
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development. You can find our Mission Statement here.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a ‘voice’ in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Read more about us here >
